表紙
市場調査レポート

電解質向け化学試薬:パイプライン分析

Electrolyte Chemistry Reagents - Pipeline Review, 2015

発行 GlobalData 商品コード 336432
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
電解質向け化学試薬:パイプライン分析 Electrolyte Chemistry Reagents - Pipeline Review, 2015
出版日: 2015年06月30日 ページ情報: 英文 53 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の電解質向け試薬 (化学薬品) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 電解質向け化学試薬の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)

第4章 電解質向け化学試薬:開発中のパイプライン製品 (企業別)

  • 電解質向け化学試薬の開発企業:パイプライン製品 (開発段階別)
  • 電解質向け化学試薬:開発段階別のパイプライン製品の一覧

第5章 電解質向け化学試薬の開発企業・製品の概要

  • Abbott Diagnostics
    • パイプライン製品および進行中の治験の概要
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Analyticon Biotechnologies AG
  • Arizona State University
  • ELITech Group
  • NanoSpeed Diagnostics Inc.
  • Vital Diagnostics, Inc.

第6章 電解質向け化学試薬:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0043EPD

GlobalData's Medical Devices sector report, "Electrolyte Chemistry Reagents - Pipeline Review, 2015" provides an overview of Electrolyte Chemistry Reagents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrolyte Chemistry Reagents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrolyte Chemistry Reagents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrolyte Chemistry Reagents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrolyte Chemistry Reagents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Electrolyte Chemistry Reagents Overview

3. Products under Development

  • 3.1. Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development
  • 3.2. Electrolyte Chemistry Reagents - Pipeline Products by Territory
  • 3.3. Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path
  • 3.4. Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date

4. Electrolyte Chemistry Reagents - Pipeline Products under Development by Companies

  • 4.1. Electrolyte Chemistry Reagents Companies - Pipeline Products by Stage of Development
  • 4.2. Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development

5. Electrolyte Chemistry Reagents Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Alfa Wassermann Diagnostic Technologies, LLC Company Overview
    • 5.2.1. Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Analyticon Biotechnologies AG Company Overview
    • 5.3.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Arizona State University Company Overview
    • 5.4.1. Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. ELITech Group Company Overview
    • 5.5.1. ELITech Group Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. NanoSpeed Diagnostics Inc. Company Overview
    • 5.6.1. NanoSpeed Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Vital Diagnostics, Inc. Company Overview
    • 5.7.1. Vital Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Electrolyte Chemistry Reagents- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development
  • Table 2: Electrolyte Chemistry Reagents - Pipeline Products by Territory
  • Table 3: Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path
  • Table 4: Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date
  • Table 5: Electrolyte Chemistry Reagents Companies - Pipeline Products by Stage of Development
  • Table 6: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development
  • Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: ARCHITECT c16000 System - Ca 72.2 Assay - Product Status
  • Table 9: ARCHITECT c16000 System - Ca 72.2 Assay - Product Description
  • Table 10: ARCHITECT c16000 System - Magnesium Enzymatic Assay - Product Status
  • Table 11: ARCHITECT c16000 System - Magnesium Enzymatic Assay - Product Description
  • Table 12: ARCHITECT c4000 - Magnesium Enzymatic Assay - Product Status
  • Table 13: ARCHITECT c4000 - Magnesium Enzymatic Assay - Product Description
  • Table 14: ARCHITECT c8000 - Magnesium Enzymatic Assay - Product Status
  • Table 15: ARCHITECT c8000 - Magnesium Enzymatic Assay - Product Description
  • Table 16: ARCHITECT c8000 System - Ca 72.2 Assay - Product Status
  • Table 17: ARCHITECT c8000 System - Ca 72.2 Assay - Product Description
  • Table 18: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Status
  • Table 19: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Description
  • Table 20: ARCHITECT ci16200 Integrated System - Magnesium Enzymatic Assay - Product Status
  • Table 21: ARCHITECT ci16200 Integrated System - Magnesium Enzymatic Assay - Product Description
  • Table 22: ARCHITECT ci4100 Integrated System - Ca 72.2 Assay - Product Status
  • Table 23: ARCHITECT ci4100 Integrated System - Ca 72.2 Assay - Product Description
  • Table 24: ARCHITECT ci4100 Integrated System - Magnesium Enzymatic Assay - Product Status
  • Table 25: ARCHITECT ci4100 Integrated System - Magnesium Enzymatic Assay - Product Description
  • Table 26: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Status
  • Table 27: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Description
  • Table 28: ARCHITECT ci8200 Integrated System - Magnesium Enzymatic Assay - Product Status
  • Table 29: ARCHITECT ci8200 Integrated System - Magnesium Enzymatic Assay - Product Description
  • Table 30: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: ACE Axcel System - Calcium Assay - Product Status
  • Table 32: ACE Axcel System - Calcium Assay - Product Description
  • Table 33: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Ammonium Lyophilisat - Product Status
  • Table 35: Ammonium Lyophilisat - Product Description
  • Table 36: Fluitest CA AIII - Product Status
  • Table 37: Fluitest CA AIII - Product Description
  • Table 38: Fluitest CA CPC - Product Status
  • Table 39: Fluitest CA CPC - Product Description
  • Table 40: Fluitest CL - Product Status
  • Table 41: Fluitest CL - Product Description
  • Table 42: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Diagnostic Assay - Osteoporosis - Product Status
  • Table 44: Diagnostic Assay - Osteoporosis - Product Description
  • Table 45: ELITech Group Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Selectra ProM Chemistry System - Magnesium Assay - Product Status
  • Table 47: Selectra ProM Chemistry System - Magnesium Assay - Product Description
  • Table 48: Selectra ProS Chemistry System - Magnesium Assay - Product Status
  • Table 49: Selectra ProS Chemistry System - Magnesium Assay - Product Description
  • Table 50: NanoSpeed Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: LFIA/Test4 Testing/Screening - Calcium - Product Status
  • Table 52: LFIA/Test4 Testing/Screening - Calcium - Product Description
  • Table 53: LFIA/Test4 Testing/Screening - Iron - Product Status
  • Table 54: LFIA/Test4 Testing/Screening - Iron - Product Description
  • Table 55: Test4Ca - Product Status
  • Table 56: Test4Ca - Product Description
  • Table 57: Vital Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Eon 300 Automated Chemistry Analyzer - UIBC Assay - Product Status
  • Table 59: Eon 300 Automated Chemistry Analyzer - UIBC Assay - Product Description
  • Table 60: Glossary

List of Figures

  • Figure 1: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development
  • Figure 2: Electrolyte Chemistry Reagents - Pipeline Products by Territory
  • Figure 3: Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path
  • Figure 4: Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date
Back to Top